NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Non-Current Assets (2020 - 2025)

NeuroSense Therapeutics' (NRSN) quarterly Non-Current Assets came in at $250000.0 in Q4 2025, up 44.51% year-over-year from $173000.0 in Q4 2024, and up 95.31% quarter-over-quarter from $128000.0 in Q2 2025.

Analysis

NeuroSense Therapeutics (NRSN) Non-Current Assets (2020 - 2025) Analysis & Trends

NeuroSense Therapeutics has disclosed Non-Current Assets across 6 years of filings, most recently posting $250000.0 for Q4 2025.

  • In Q4 2025, Non-Current Assets rose 44.51% year-over-year to $250000.0; the TTM figure through Dec 2025 stood at $250000.0 (up 44.51% YoY), while the FY2025 annual figure was $250000.0, up 44.51% from the prior year.
  • Non-Current Assets came in at $250000.0 for Q4 2025 at NeuroSense Therapeutics, up from $128000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $349000.0 in Q2 2022 to a low of $19000.0 in Q4 2021.
  • Average Non-Current Assets over 5 years is $251400.0, with a median of $269000.0 recorded in 2023.
  • Year-over-year, Non-Current Assets soared 1668.42% in 2022 and plunged 42.34% in 2025.
  • Over 5 years, Non-Current Assets stood at $19000.0 in 2021, then soared by 1668.42% to $336000.0 in 2022, then slipped by 19.94% to $269000.0 in 2023, then slumped by 35.69% to $173000.0 in 2024, then surged by 44.51% to $250000.0 in 2025.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $250000.0 in Q4 2025, $128000.0 in Q2 2025, and $173000.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 60.68 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 35.42 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 14.88 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 23.28 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 5.15 Bn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 1.96 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 938.60 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn 24.78 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn 564.41 Mn
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn - 250,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 250,000.00
Jun 30, 2025 128,000.00
Dec 31, 2024 173,000.00
Sep 30, 2024 199,000.00
Jun 30, 2024 222,000.00
Mar 31, 2024 254,000.00
Dec 31, 2023 269,000.00
Sep 30, 2023 281,000.00
Jun 30, 2023 307,000.00
Mar 31, 2023 317,000.00
Dec 31, 2022 336,000.00
Sep 30, 2022 338,000.00
Jun 30, 2022 349,000.00
Mar 31, 2022 329,000.00
Dec 31, 2021 19,000.00
Dec 31, 2020 13,000.00
API Access

NeuroSense Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=NRSN&period=max&api_key=YOUR_API_KEY